In Georgia: Sudden surge in overdoses related to street drugs sold as yellow opioid pain medication

Post Date: 
June 29 2017

New York City issues Health Advisory about overdoses from fentanyl added to cocaine

Post Date: 
June 6 2017

Gulf Coast HIDTA and the Georgia Bureau of Investigation Issue Synthetic Opioids Alert

Post Date: 
May 16 2017

DEA Temporarily Bans Synthetic Opioid U-47700 ("Pink"), Linked to Nearly 50 Deaths

Post Date: 
November 15 2016

Fake Prescription Drugs Laced with Fentanyl

Post Date: 
May 5 2016

Teen Opioid Prescriptions Raise Risk of Later Opioid Misuse

A new study using data from the NIDA-funded Monitoring the Future survey of adolescent drug use and attitudes conducted annually by the University of Michigan shows that teens who received a prescription for opioid pain medication by Grade 12 were at 33 percent increased risk of misusing an opioid between ages 19 and 25.

November 2015

Two computerized programs improved outcomes when they were used to supplement or partially replace in-person behavioral therapy for drug addiction in recent NIDA-sponsored trials.

FDA approves naloxone nasal spray to reverse opioid overdose

The new technology has an easy-to-use, needle-free design, providing family members, caregivers and first responders with an alternative to injectable naloxone for use during a suspected opioid overdose.

NARCAN Nasal Spray: Life-Saving Science at NIDA

The FDA announced its approval of the NARCAN Nasal Spray, an intranasal naloxone formula that can immediately restore normal breathing in a person overdosing on prescription opioids or heroin and thus save their life.

NIDA redesigns Easy to Read and Learn the Link websites for mobile devices

This new responsive design model automatically adjusts each page to fit the viewer’s screen for faster and easier viewing and navigation on a variety of mobile platforms, such as smartphones and tablets.